Active, not recruitingNot applicableNCT05672992

Longitudinal Spatial Frequency Domain Imaging Study

Studying Diffuse cutaneous systemic sclerosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Boston University
Principal Investigator
Andreea Bujor, MD, PhD
BU Chobanian & Advesian School of Medicine
Intervention
Spatial-frequency domain imaging (SFDI)(other)
Enrollment
78 enrolled
Eligibility
18 years · All sexes
Timeline
2023 – 2028

Study locations (1)

Collaborators

Scleroderma Clinical Trials Consortium (SCTC) · Fibrosis ARC: Connecting Tissues and Investigators (FCTI ARC)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05672992 on ClinicalTrials.gov

Other trials for Diffuse cutaneous systemic sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Diffuse cutaneous systemic sclerosis →

← Back to all trials